Clinical Trials Logo

Subarachnoid Neurocysticercosis clinical trials

View clinical trials related to Subarachnoid Neurocysticercosis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT03950037 Withdrawn - Clinical trials for Subarachnoid Neurocysticercosis

SANCC: Clinical Trial Early Intervention

Start date: January 1, 2022
Phase: Phase 2
Study type: Interventional

Subarachnoid neurocysticercosis (SANCC) is a severe infection of the brain by the tapeworm Taenia solium. People who have this infection are usually diagnosed late in the disease process leading to very poor prognosis. This trial studies the safety of early medical intervention in people who have SANCC but do not have symptoms. The trial will enroll 18 participants in Peru.